December 8, 2025BloodOpen Access

Activation of pyruvate kinase by mitapivat potentially rescues ineffective erythropoiesis in models of diamond blackfan anemia.

View Full Paper

Ask AI

Bookmark

Authors

JWJonathan R.A. de WildeFeinstein Institute for Medical Research ABAlexis BertrandNorthwell Health NTNaomi TaylorCentre National de la Recherche Scientifique

Discussion

Member takes

Implication

Observational analysis showed mitapivat improved erythropoiesis in Rpl5-haploinsufficient mice, suggesting enhanced cell differentiation and reduced ferroptosis.

Key Points

Mitapivat treatment increased cell counts in Rpl5-haploinsufficient progenitors, improving erythropoiesis.
Control and Rps19 cells had stable differentiation, with pro- to polychromatic erythroblast ratios remaining similar.
Erythroid progenitor differentiation was marginally enhanced in Rpl5 haploinsufficient cells treated with mitapivat.
Diamond-Blackfan anemia highlights distinct cell death mechanisms between Rps19 and Rpl5 haploinsufficient models.

Cite This Study

Wilde et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d328 https://doi.org/10.1182/blood-2025-1121

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis showed mitapivat improved erythropoiesis in Rpl5-haploinsufficient mice, suggesting enhanced cell differentiation and reduced ferroptosis.

Activation of pyruvate kinase by mitapivat potentially rescues ineffective erythropoiesis in models of diamond blackfan anemia.

Discussion

Member takes

Implication

Key Points

Cite This Study

Activation of pyruvate kinase by mitapivat potentially rescues ineffective erythropoiesis in models of diamond blackfan anemia.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider